These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 8758533)

  • 1. [Hypomagnesemic and hypocalcemic coma, convulsions and ocular motility disorders after chemotherapy with platinum compounds].
    Bachmeyer C; Decroix Y; Médioni J; Dhôte R; Benfiguig K; Houillier P; Grateau G
    Rev Med Interne; 1996; 17(6):467-9. PubMed ID: 8758533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Convulsions in a patient treated for ovarian adenocarcinoma].
    Le Moing V; Wechsler B; Godeau P; Zylberait D
    Rev Med Interne; 1996; 17 Suppl 2():234s-236s. PubMed ID: 8760667
    [No Abstract]   [Full Text] [Related]  

  • 3. Cisplatin-induced hypocalcemia and hypomagnesemia.
    Lyman NW; Hemalatha C; Viscuso RL; Jacobs MG
    Arch Intern Med; 1980 Nov; 140(11):1513-4. PubMed ID: 7192079
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Hypocalcemic hypomagnesemic coma after carboplatin].
    Beuzeboc P; Deygere H; Boccaccio F; Christoforov B
    Presse Med; 1989 Sep 2-9; 18(27):1343-4. PubMed ID: 2529502
    [No Abstract]   [Full Text] [Related]  

  • 5. Magnesium homeostasis following chemotherapy with cisplatin: a prospective study.
    Stewart AF; Keating T; Schwartz PE
    Am J Obstet Gynecol; 1985 Nov; 153(6):660-5. PubMed ID: 4061536
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cisplatin-induced hypomagnesemic hypocalcemia.
    Hill JB; Russo A
    Arch Intern Med; 1981 Jul; 141(8):1100. PubMed ID: 7195693
    [No Abstract]   [Full Text] [Related]  

  • 7. Cisplatin-induced hypomagnesemia with seizures: a case report and review of the literature.
    Bellin SL; Selim M
    Gynecol Oncol; 1988 May; 30(1):104-13. PubMed ID: 3284791
    [No Abstract]   [Full Text] [Related]  

  • 8. A case of chronic hypomagnesemia in a cancer survivor.
    Velimirovic M; Ziperstein JC; Fenves AZ
    Hosp Pract (1995); 2017 Apr; 45(2):58-64. PubMed ID: 28114816
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cis-platinum-induced renal sodium wasting.
    Lammers PJ; White L; Ettinger LJ
    Med Pediatr Oncol; 1984; 12(5):343-6. PubMed ID: 6541750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cisplatin and renal magnesium wasting.
    Winkler CF; Mahr MM; DeBandi H
    Ann Intern Med; 1979 Sep; 91(3):502-3. PubMed ID: 475203
    [No Abstract]   [Full Text] [Related]  

  • 11. [Hypocalcemia caused by hypomagnesemia during a treatment with cisplatin].
    Brousse C; Baumelou E; Mignot L
    Rev Med Interne; 1996; 17(6):498. PubMed ID: 8758540
    [No Abstract]   [Full Text] [Related]  

  • 12. Life-threatening hypocalcemia and hypomagnesemia associated with cisplatin chemotherapy.
    Gonzalez C; Villasanta U
    Obstet Gynecol; 1982 Jun; 59(6):732-4. PubMed ID: 7200596
    [No Abstract]   [Full Text] [Related]  

  • 13. Persistent hypomagnesemia following cisplatin chemotherapy in patients with ovarian cancer.
    Markmann M; Rothman R; Reichman B; Hakes T; Lewis JL; Rubin S; Jones W; Almadrones L; Hoskins W
    J Cancer Res Clin Oncol; 1991; 117(2):89-90. PubMed ID: 2007614
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Platinum agents and secondary myeloid leukaemia: two cases treated only with platinum-based drugs.
    Philpott NJ; Elebute MO; Powles R; Treleaven JG; Gore M; Dainton MG; Min T; Swansbury GJ; Catovsky D
    Br J Haematol; 1996 Jun; 93(4):884-7. PubMed ID: 8703821
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety of cisplatin after severe hypersensitivity reactions to carboplatin in patients with recurrent ovarian carcinoma.
    Ottaiano A; Tambaro R; Greggi S; Prato R; Di Maio M; Esposito G; Scala F; Barletta E; Losito S; De Vivo R; Iaffaioli VR; Pignata S
    Anticancer Res; 2003; 23(4):3465-8. PubMed ID: 12926091
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tetany due to hypomagnesemia induced by cisplatin and doxorubicin treatment for synovial sarcoma.
    Mune T; Yasuda K; Ishii M; Matsunaga T; Miura K
    Intern Med; 1993 May; 32(5):434-7. PubMed ID: 8400511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Administration of cisplatin in three patients with carboplatin hypersensitivity: is skin testing useful?
    Syrigou E; Makrilia N; Vassias A; Nikolaidis I; Xyla V; Manolopoulos L; Syrigos K
    Anticancer Drugs; 2010 Mar; 21(3):333-8. PubMed ID: 20038831
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ocular motility changes after subtenon carboplatin chemotherapy for retinoblastoma.
    Mulvihill A; Budning A; Jay V; Vandenhoven C; Heon E; Gallie BL; Chan HS
    Arch Ophthalmol; 2003 Aug; 121(8):1120-4. PubMed ID: 12912689
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypomagnesemic hypokalemia and hypocalcemia: clinical and laboratory characteristics.
    Elisaf M; Milionis H; Siamopoulos KC
    Miner Electrolyte Metab; 1997; 23(2):105-12. PubMed ID: 9252977
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypomagnesemia following high-dose intracavitary cisplatin with systemically administered sodium thiosulfate.
    Markman M; Cleary S; Howell SB
    Am J Clin Oncol; 1986 Oct; 9(5):440-3. PubMed ID: 3776908
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.